Hygieia touts 99% D-chiro-inositol biomanufacturing platform for women’s health products

Hygieia says its enzyme-driven production process for D-chiro-inositol is designed to deliver 99% or higher structural purity for women’s hormonal and metabolic health products. The company is positioning the ingredient and its OEM/ODM services for nutraceutical, beauty, biomedicine and functional wellness brands worldwide.

Why it matters: - D-chiro-inositol is positioned as a core ingredient for women’s hormonal and metabolic health, including glucose metabolism and ovarian endocrine support. - Hygieia is targeting formulators and brand owners that need high-purity chiral raw materials with consistent batch quality. - The company is also pushing a greener manufacturing model that aims to reduce solvents, energy use and chemical byproducts.

What happened: - Hygieia introduced its D-chiro-inositol manufacturing and OEM/ODM offering from Shenzhen, Guangdong, China, on October 23, 2026. - The company says its proprietary Zymevolver(R) strain construction technology and enzyme engineering evolution platform support production of D-chiro-inositol. - Hygieia says the process delivers D-chiro-inositol powder with structural purity of 99% or higher. - More information is available on the company’s official portal.

The details: - D-chiro-inositol is described as a naturally occurring polyol and a secondary messenger in insulin signal transduction. - The ingredient is said to support glycogen synthesis, oxidative glucose disposal and peripheral tissue glucose use. - Hygieia says D-chiro-inositol also helps modulate steroidogenesis and balanced androgenic activity in ovarian tissue. - The company says optical purity and chemical integrity are essential because unwanted stereoisomers or synthesis byproducts can affect bioavailability and receptor responsiveness. - The manufacturing output is described as a white crystalline powder with CAS number 643-12-9 and molecular weight 180.16. - Hygieia says the powder shows neutral pH stability in aqueous solution and strong water solubility. - The company says it screens batches for heavy metals, microbial limits and solvent residues. - Hygieia says it uses high-performance liquid chromatography and optical rotation verification to confirm identity, potency and chiral purity. - Every delivery includes a batch-specific Certificate of Analysis, Safety Data Sheet and technical specification sheet. - Hygieia says its OEM and ODM services cover raw material development and custom synthesis, formulation optimization, custom formula design and finished product contract manufacturing. - The company lists hard capsules, direct-to-mouth powder stick packs, tableting and liquid sachets as available dosage formats. - Hygieia says it can tailor particle size, density and bulk specifications to production line needs. - The company says it can combine D-chiro-inositol with other bio-actives such as 5-methyltetrahydrofolate, also called L-5-MTHF, or Calcium AKG.

Between the lines: - The pitch reflects a broader move in nutraceuticals toward science-backed, single-ingredient positioning paired with full-service manufacturing. - Hygieia is trying to compete on both ingredient quality and downstream product development support, which can matter for brands seeking faster launch timelines. - The emphasis on green biomanufacturing suggests the company is also aiming to appeal to buyers focused on sustainability and supply-chain transparency.

What's next: - Hygieia is inviting technical specification requests, sample requests and custom OEM formulation consultations through its corporate site. - The company appears to be expanding its role from raw material supplier to end-to-end manufacturing partner for global wellness brands. - Further commercial adoption will likely depend on how brands evaluate the ingredient’s documentation, consistency and formulation fit.